Albany, NY -- (SBWIRE) -- 09/21/2012 -- The global pediatric vaccine market is forecasted to reach $24.3 billion by the year 2017 at a compounded annual growth rate of 11.5 % during 2011-2017. This growth in revenues is expected to be driven by the introduction of new molecules that are currently in regulatory filing stage and those in later stage of development.
Read More: Pediatric Vaccines Market
The vaccines market has become high revenue generators despite being priced at a premium because of increasing occurrences of acute diseases and growing elderly population. The vaccine market has captured the attention of big pharmaceutical companies that have been watching the progress of this market. Establishment of public-private partnerships is helping in development of new vaccines for diseases which is also expected to drive the growth of pediatric vaccines and introduce new technologies in the market.
Segmentation Based on Product
- Pediatric Vaccines
- Pediatric Hormones
- Allergy & Respiratory Drugs
- Anti-infective Drugs
- CNS Drugs
- Other Pediatric Drugs
Research report on pediatric vaccines market analyzes this market based on its market segments and major geographies. This report is a comprehensive analysis of
- Current trends in market
- Industry growth drivers
- Factors affecting market growth
- Market structure
- Industry projections for upcoming years
Browse More Reports on Pharmaceutical Markets
This report also includes detailed analysis of technological improvements in the field, Porter’s five force model analysis, and complete company profiles of top industry players.Report provides review of micro and macro factors significant with respect to new entrants and existing market players with value chain analysis.
Geographies analyzed under this research report are
- North America
- Asia Pacific
- Rest of the World
Some of the major players dominating this market are GlaxoSmithKline, Sanofi, Pfizer, Novartis AG., Merck & Co. Inc, Abbott Laboratories, Amgen, Inc., AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Genentech, Inc., Novo Nordisk A/S, Shionogi, Inc., Shire Pharmaceuticals Group Plc, and others.
Reasons for Buying this Report
- Report provides clear understanding of changing competitive dynamics and keeps you ahead of competitors
- It provides technological growth map over time and explains its impact on market
- It helps in making informed business decisions by making in-depth analysis of market
- It also provides up-to-date analysis of latest trends in market and helps you stay updated with recent technological improvements
- This research report provides overview of major market forces driving and restraining market growth
- Report provides detailed analysis of major competitors and their strategies
- It provides distinctive graphics and exemplified SWOT analysis of major industry segments
To BUY This Report Kindly Visit Us @:
About Transparency Market Research
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
90 Sate Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453